169 related articles for article (PubMed ID: 31945397)
41. In-vitro and in-silico investigation of protective mechanisms of crocin against E46K α-synuclein amyloid formation.
Ghasemi Tigan M; Ghahghaei A; Lagzian M
Mol Biol Rep; 2019 Aug; 46(4):4279-4292. PubMed ID: 31111370
[TBL] [Abstract][Full Text] [Related]
42. A four-amino acid linker between repeats in the α-synuclein sequence is important for fibril formation.
Shvadchak VV; Subramaniam V
Biochemistry; 2014 Jan; 53(2):279-81. PubMed ID: 24397337
[TBL] [Abstract][Full Text] [Related]
43. Pressure effects on α-synuclein amyloid fibrils: An experimental investigation on their dissociation and reversible nature.
Piccirilli F; Plotegher N; Spinozzi F; Bubacco L; Mariani P; Beltramini M; Tessari I; Militello V; Perucchi A; Amenitsch H; Baldassarri E; Steinhart M; Lupi S; Ortore MG
Arch Biochem Biophys; 2017 Aug; 627():46-55. PubMed ID: 28624352
[TBL] [Abstract][Full Text] [Related]
44. A simple, versatile and robust centrifugation-based filtration protocol for the isolation and quantification of α-synuclein monomers, oligomers and fibrils: Towards improving experimental reproducibility in α-synuclein research.
Kumar ST; Donzelli S; Chiki A; Syed MMK; Lashuel HA
J Neurochem; 2020 Apr; 153(1):103-119. PubMed ID: 31925956
[TBL] [Abstract][Full Text] [Related]
45. The role of stable α-synuclein oligomers in the molecular events underlying amyloid formation.
Lorenzen N; Nielsen SB; Buell AK; Kaspersen JD; Arosio P; Vad BS; Paslawski W; Christiansen G; Valnickova-Hansen Z; Andreasen M; Enghild JJ; Pedersen JS; Dobson CM; Knowles TP; Otzen DE
J Am Chem Soc; 2014 Mar; 136(10):3859-68. PubMed ID: 24527756
[TBL] [Abstract][Full Text] [Related]
46. α-synuclein interaction with zero-valent iron nanoparticles accelerates structural rearrangement into amyloid-susceptible structure with increased cytotoxic tendency.
Tahaei Gilan SS; Yahya Rayat D; Mustafa TA; Aziz FM; Shahpasand K; Akhtari K; Salihi A; Abou-Zied OK; Falahati M
Int J Nanomedicine; 2019; 14():4637-4648. PubMed ID: 31417259
[TBL] [Abstract][Full Text] [Related]
47. Stabilization of α-Synuclein Fibril Clusters Prevents Fragmentation and Reduces Seeding Activity and Toxicity.
Lam HT; Graber MC; Gentry KA; Bieschke J
Biochemistry; 2016 Feb; 55(4):675-85. PubMed ID: 26799377
[TBL] [Abstract][Full Text] [Related]
48. Modulating α-synuclein fibril formation using DNA tetrahedron nanostructures.
Yoo WK; Ryu BH; Kim KR; Wang Y; Le LTHL; Lee JH; Kim KK; Toth G; Ahn DR; Doohun Kim T
Biochim Biophys Acta Gen Subj; 2019 Jan; 1863(1):73-81. PubMed ID: 30278239
[TBL] [Abstract][Full Text] [Related]
49. Dimerization of Tyr136Cys alpha-synuclein prevents amyloid transformation of wild type alpha-synuclein.
Barinova KV; Kuravsky ML; Arutyunyan AM; Serebryakova MV; Schmalhausen EV; Muronetz VI
Int J Biol Macromol; 2017 Mar; 96():35-43. PubMed ID: 27939273
[TBL] [Abstract][Full Text] [Related]
50. Polymorph-specific distribution of binding sites determines thioflavin-T fluorescence intensity in α-synuclein fibrils.
Sidhu A; Vaneyck J; Blum C; Segers-Nolten I; Subramaniam V
Amyloid; 2018 Sep; 25(3):189-196. PubMed ID: 30486688
[TBL] [Abstract][Full Text] [Related]
51. Analysis of sheep α-synuclein provides a molecular strategy for the reduction of fibrillation.
Bickle L; Hopwood JJ; Karageorgos L
Biochim Biophys Acta Proteins Proteom; 2017 Mar; 1865(3):261-273. PubMed ID: 28007442
[TBL] [Abstract][Full Text] [Related]
52. Amplification of distinct α-synuclein fibril conformers through protein misfolding cyclic amplification.
Jung BC; Lim YJ; Bae EJ; Lee JS; Choi MS; Lee MK; Lee HJ; Kim YS; Lee SJ
Exp Mol Med; 2017 Apr; 49(4):e314. PubMed ID: 28386127
[TBL] [Abstract][Full Text] [Related]
53. β-Synuclein suppresses both the initiation and amplification steps of α-synuclein aggregation via competitive binding to surfaces.
Brown JW; Buell AK; Michaels TC; Meisl G; Carozza J; Flagmeier P; Vendruscolo M; Knowles TP; Dobson CM; Galvagnion C
Sci Rep; 2016 Nov; 6():36010. PubMed ID: 27808107
[TBL] [Abstract][Full Text] [Related]
54. Heme Stabilization of α-Synuclein Oligomers during Amyloid Fibril Formation.
Hayden EY; Kaur P; Williams TL; Matsui H; Yeh SR; Rousseau DL
Biochemistry; 2015 Aug; 54(30):4599-610. PubMed ID: 26161848
[TBL] [Abstract][Full Text] [Related]
55. Structure-Based Discovery of Small-Molecule Inhibitors of the Autocatalytic Proliferation of α-Synuclein Aggregates.
Chia S; Faidon Brotzakis Z; Horne RI; Possenti A; Mannini B; Cataldi R; Nowinska M; Staats R; Linse S; Knowles TPJ; Habchi J; Vendruscolo M
Mol Pharm; 2023 Jan; 20(1):183-193. PubMed ID: 36374974
[TBL] [Abstract][Full Text] [Related]
56. Role of different regions of alpha-synuclein in the assembly of fibrils.
Qin Z; Hu D; Han S; Hong DP; Fink AL
Biochemistry; 2007 Nov; 46(46):13322-30. PubMed ID: 17963364
[TBL] [Abstract][Full Text] [Related]
57. The A53E α-synuclein pathological mutation demonstrates reduced aggregation propensity in vitro and in cell culture.
Rutherford NJ; Giasson BI
Neurosci Lett; 2015 Jun; 597():43-8. PubMed ID: 25892596
[TBL] [Abstract][Full Text] [Related]
58. SDS-induced fibrillation of alpha-synuclein: an alternative fibrillation pathway.
Giehm L; Oliveira CL; Christiansen G; Pedersen JS; Otzen DE
J Mol Biol; 2010 Aug; 401(1):115-33. PubMed ID: 20540950
[TBL] [Abstract][Full Text] [Related]
59. Glycosaminoglycans have variable effects on α-synuclein aggregation and differentially affect the activities of the resulting amyloid fibrils.
Mehra S; Ghosh D; Kumar R; Mondal M; Gadhe LG; Das S; Anoop A; Jha NN; Jacob RS; Chatterjee D; Ray S; Singh N; Kumar A; Maji SK
J Biol Chem; 2018 Aug; 293(34):12975-12991. PubMed ID: 29959225
[TBL] [Abstract][Full Text] [Related]
60. Modulation of α-synuclein fibrillation by plant metabolites, daidzein, fisetin and scopoletin under physiological conditions.
Rane AR; Paithankar H; Hosur RV; Choudhary S
Int J Biol Macromol; 2021 Jul; 182():1278-1291. PubMed ID: 33991558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
